How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?
Novel Inhaled Vaccine for Tuberculosis Shows Strong Immune Response in Mice
Vaccine Delays Reveal Weak Link in Supply Chains: A Shortage of Workers
At Risk of Extinction, Black-Footed Ferrets Get Experimental COVID Vaccine
FDA Authorizes Moderna COVID-19 mRNA Vaccine for Emergency Use
Hospitals Scramble to Prioritize Which Workers Are First for COVID Shots
How COVID-19 Vaccines Will Get From the Factory to Your Community
Vaccines Against SARS-CoV-2 Will Have Side Effects – That’s A Good Thing
CONVINCE USA Aims to Address Public Concerns About COVID-19 Vaccine
OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics
Oxford-AstraZeneca COVID-19 Vaccine: Cheaper and Doesn’t Require Supercold Storage Quagmire
Altimmune Poised to Begin Phase 1 Clinical Trial of Single-Dose Intranasal COVID-19 Vaccine
COVID-19 Vaccines Were Developed in Record Time – But are These Game-Changers Safe?
Pfizer and BioNTech Submit COVID-19 Vaccine for Emergency Use Approval in U.S.
NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates
Until a Coronavirus Vaccine is Ready, Pneumonia Vaccines May Reduce Deaths from COVID-19
U.S. Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva
Pipeline COVID-19 Vaccines Not Affected by ‘G-Strain’ Mutation
Congratulations. You've reached the end of the internet.
Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response
Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2
Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks
Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3
ABSA’s 1st Biosecurity Symposium
© 2021 by Stemar Media Group LLC
Back to Top